標(biāo)題: Titlebook: Resistance to Targeted ABC Transporters in Cancer; Thomas Efferth Book 2015 Springer International Publishing Switzerland 2015 P-glycoprot [打印本頁] 作者: memoir 時(shí)間: 2025-3-21 19:04
書目名稱Resistance to Targeted ABC Transporters in Cancer影響因子(影響力)
書目名稱Resistance to Targeted ABC Transporters in Cancer影響因子(影響力)學(xué)科排名
書目名稱Resistance to Targeted ABC Transporters in Cancer網(wǎng)絡(luò)公開度
書目名稱Resistance to Targeted ABC Transporters in Cancer網(wǎng)絡(luò)公開度學(xué)科排名
書目名稱Resistance to Targeted ABC Transporters in Cancer被引頻次
書目名稱Resistance to Targeted ABC Transporters in Cancer被引頻次學(xué)科排名
書目名稱Resistance to Targeted ABC Transporters in Cancer年度引用
書目名稱Resistance to Targeted ABC Transporters in Cancer年度引用學(xué)科排名
書目名稱Resistance to Targeted ABC Transporters in Cancer讀者反饋
書目名稱Resistance to Targeted ABC Transporters in Cancer讀者反饋學(xué)科排名
作者: nocturnal 時(shí)間: 2025-3-21 20:47
E. A. Roundhill,J. I. Fletcher,M. Haber,M. D. Norris besten K?pfe besch?ftigte.. Der erste, der das Brechungsgesetz auf Grund vieler Messungen durch eine geometrische Konstruktion richtig beschrieben hat, ist . (1581–1626); aber das Manuskript von ., das . noch einsehen konnte, ist verschollen, und die Tatsache, da? . das Brechungsgesetz entdeckt hat作者: 有花 時(shí)間: 2025-3-22 02:15
Karthika Natarajan Ph.D.,Maria R. Baer M.D.,Douglas D. Ross M.D., Ph.D. ein; es tritt also dabei eine Teilung des Lichts in mindestens zwei Teile ein. Bei ebenen und sonstwie gesetzm??ig geformten, z. B. sph?rischen spiegelnden Fl?chen, kann man durch den Versuch und an Hand der Fresnel schen Formeln den Anteil des gespiegelten und des gebrochenen Lichts ermitteln; er 作者: Irascible 時(shí)間: 2025-3-22 07:37 作者: 創(chuàng)造性 時(shí)間: 2025-3-22 12:04 作者: Pigeon 時(shí)間: 2025-3-22 15:33 作者: –吃 時(shí)間: 2025-3-22 19:26 作者: Affirm 時(shí)間: 2025-3-22 21:45 作者: 破譯 時(shí)間: 2025-3-23 02:50
Atish Patel,De-Shen Wang,Hong-May Sim,Suresh V. Ambudkar,Zhe-Sheng Chen M.D., Ph.D.作者: Obstruction 時(shí)間: 2025-3-23 06:51
Atish Patel,De-Shen Wang,Hong-May Sim,Suresh V. Ambudkar,Zhe-Sheng Chen M.D., Ph.D.作者: 記成螞蟻 時(shí)間: 2025-3-23 10:17 作者: idiopathic 時(shí)間: 2025-3-23 15:10
Role of P-Glycoprotein for Resistance of Tumors to Anticancer Drugs: From Bench to Bedside,ouse tumor lines, we investigated inherent drug resistance in human lung xenograft tumors transplanted to nude mice. Drug resistance in these xenografts was also associated with overexpression of P-glycoprotein and . mRNA, but without . gene amplification. Furthermore, we explored P-glycoprotein exp作者: collateral 時(shí)間: 2025-3-23 20:27
Clinical Relevance of Multidrug-Resistance-Proteins (MRPs) for Anticancer Drug Resistance and Prognibute directly to drug resistance based on in vivo models and patient data. We will also discuss the value of MRP expression as a prognostic marker and its potential role in selecting treatment protocols and examine existing and novel strategies to target MRPs.作者: ERUPT 時(shí)間: 2025-3-24 01:32
A New Strategy of ALA-Photodynamic Cancer Therapy: Inhibition of ABC Transporter ABCG2, target genes, including those for metabolizing enzymes and transporters essential for cellular defense. Whereas Nrf2 upregulates transcription of the . gene to confer cancer cells resistance, several protein kinase inhibitors reportedly interfere with the transport function of ABCG2. In fact, gefit作者: PET-scan 時(shí)間: 2025-3-24 02:20 作者: 結(jié)束 時(shí)間: 2025-3-24 08:54 作者: Lipohypertrophy 時(shí)間: 2025-3-24 11:48
ABC Transporter Modulatory Drugs from Marine Sources: A New Approach to Overcome Drug Resistance in patients. Overcoming this pathway of resistance with the use of modulators to block the drug efflux transporters has shown some promise in recent years. However, there is still room for improvement in designing the clinical strategy and developing newer agents to overcome MDR. Nature has provided r作者: carotid-bruit 時(shí)間: 2025-3-24 16:29
The Role of ABC Multidrug Transporters in Resistance to Targeted Anticancer Kinase Inhibitors,hanism of TKI action. In this review, we present the key TKIs currently used in cancer therapy, and discuss their interactions with MDR-ABC transporters. We also describe the methods for studying various forms of direct MDR-ABC and TKI interactions, and present a framework for understanding a comple作者: 頂點(diǎn) 時(shí)間: 2025-3-24 23:02
Drugs Affecting Epigenetic Modifications of ABC Transporters for Drug Resistance,igenetic modifications of the genes have been emerging as a part cause of ABC transporter-mediated drug resistance. In this chapter, therefore, epigenetic modifications of the ABC transporter genes are covered, where the outlines of the regulatory mechanisms and factors involved in the epigenetic mo作者: CHAR 時(shí)間: 2025-3-25 00:46 作者: lobster 時(shí)間: 2025-3-25 04:09
2196-5501 , the potential of radiopharmaceuticals for diagnosis of multidrug-resistant tumors and of nanotechnology to combat drug-resistant tumors is also?discussed.978-3-319-37996-8978-3-319-09801-2Series ISSN 2196-5501 Series E-ISSN 2196-551X 作者: BAIL 時(shí)間: 2025-3-25 09:33
Book 2015compounds used in photodynamic therapy, tyrosine kinase inhibitors and others. Furthermore, the potential of radiopharmaceuticals for diagnosis of multidrug-resistant tumors and of nanotechnology to combat drug-resistant tumors is also?discussed.作者: Chauvinistic 時(shí)間: 2025-3-25 14:11
Manfred Volm,Thomas Efferthei der ?nderung der Geschwindigkeit, die das Licht beim übergang von einem Medium in das andere erleidet, die Komponente der Geschwindigkeit, die der (ebenen) Trennungsfl?che parallel ist, constant bleiben mu?, w?hrend die absoluten Geschwindigkeiten auf beiden Seiten dieser Fl?che ein festes Verh?l作者: MENT 時(shí)間: 2025-3-25 18:37
E. A. Roundhill,J. I. Fletcher,M. Haber,M. D. Norrisei der ?nderung der Geschwindigkeit, die das Licht beim übergang von einem Medium in das andere erleidet, die Komponente der Geschwindigkeit, die der (ebenen) Trennungsfl?che parallel ist, constant bleiben mu?, w?hrend die absoluten Geschwindigkeiten auf beiden Seiten dieser Fl?che ein festes Verh?l作者: miracle 時(shí)間: 2025-3-25 23:30
Karthika Natarajan Ph.D.,Maria R. Baer M.D.,Douglas D. Ross M.D., Ph.D.lenden Strahlenbüschels kann also als Mittel benutzt werden, um verschieden starke Anteile des Lichts zurückzuwerfen. Spiegelfl?chen an massiven Metallstücken dagegen zeigen diese Abh?ngigkeit des Reflexionsverm?gens vom Einfallswinkel nicht;dafür hat aber jedes spiegelnde Metall seinen eigenen Refl作者: 好開玩笑 時(shí)間: 2025-3-26 03:27
Toshihisa Ishikawa Ph.D.,Yutaka Inoue,Yoji Ikegami,Takahiro Fujishiro,Tomohiro Osaki,Yoshinaga Kajimlenden Strahlenbüschels kann also als Mittel benutzt werden, um verschieden starke Anteile des Lichts zurückzuwerfen. Spiegelfl?chen an massiven Metallstücken dagegen zeigen diese Abh?ngigkeit des Reflexionsverm?gens vom Einfallswinkel nicht;dafür hat aber jedes spiegelnde Metall seinen eigenen Refl作者: 沖突 時(shí)間: 2025-3-26 04:42
Csilla Hegedüs,Tamás Hegedüs,Balázs Sarkadit also zwei Me?punkte auf ... Speziell liefert jede Tiefenebene, deren Fluchtlinie stets durch H geht, zwei Me?punkte auf dem Distanzkreis. So ist in 3.2 der Punkt O. ein Winkelme?punkt aller Profilebenen λ und deshalb jetzt mit O. zu bezeichnen. Daher gilt allgemein:作者: 刻苦讀書 時(shí)間: 2025-3-26 10:40 作者: Hyperplasia 時(shí)間: 2025-3-26 13:30
2196-5501 gnosis of multidrug-resistant tumors and of nanotechnology tThis critical review volume explores the theme of ABC transporters in the context of basic cancer research and its?role in drug-resistant tumors. The?chapters provided?complement basic research by including?investigations from translational作者: 指令 時(shí)間: 2025-3-26 19:04 作者: amygdala 時(shí)間: 2025-3-26 22:44
Clinical Relevance of Multidrug-Resistance-Proteins (MRPs) for Anticancer Drug Resistance and Progny of multidrug transporters belong to the Multidrug Resistance Protein (MRP) family, also known as the ABCC family, which includes MRP1–9. These proteins are typically found in the plasma membrane of cells, where they efflux a broad range of both physiological substrates and xenobiotics, including a作者: abject 時(shí)間: 2025-3-27 03:39
Role of Breast Cancer Resistance Protein (BCRP, ABCG2) in Cancer Outcomes and Drug Resistance,ant role in altering absorption, distribution, metabolism, and excretion (ADME) of most extant and emerging molecular cancer therapeutics. BCRP expressed by neoplastic cells may also contribute to the resistance of these cells to chemotherapeutic agents. Although the expression of BCRP in human canc作者: magnate 時(shí)間: 2025-3-27 07:14 作者: Geyser 時(shí)間: 2025-3-27 10:35
ATP Binding Cassette Transporters in Cancer Stem-Like Cells,ing and sustaining the growth of a tumor, being responsible for tumor initiation, invasive growth, metastasis, and drug resistance. The isolation of CSC is not easy to achieve due to the need for proving phenotypic and functional features; thus, under many circumstances “putative CSC” is the most ap作者: 里程碑 時(shí)間: 2025-3-27 14:16 作者: 可忽略 時(shí)間: 2025-3-27 19:13
Modulation of P-Glycoprotein-Mediated Multidrug Resistance by Synthetic and Phytochemical Small Moluring the past three decades, many efforts have been spent to develop strategies to overcome multidrug resistance. Many chemical compounds have been shown to inhibit the drug efflux of the multidrug-resistance-mediating P-glycoprotein. Chemical P-glycoprotein inhibitors are from the classes of calci作者: ASSET 時(shí)間: 2025-3-28 00:45 作者: GRIPE 時(shí)間: 2025-3-28 03:51
The Role of ABC Multidrug Transporters in Resistance to Targeted Anticancer Kinase Inhibitors,ted kinase inhibitors (TKIs), which are specifically capable of eliminating key pathways driving cancer growth and metastasis, are also applied in cancer treatment. The hydrophobic TKI molecules need to pass the cell membrane to reach their intracellular targets, and in many cases become substrates 作者: 使厭惡 時(shí)間: 2025-3-28 08:32
Nanotechnology to Combat Multidrug Resistance in Cancer,involving abnormal vasculature, localized area of hypoxia, upregulated ABC transporters, aerobic glycolysis, elevated apoptotic threshold, and increased interstitial fluid pressure. Nanomedicines in targeted cancer chemotherapy hold great promise as an effective approach to prevail over MDR. Extensi作者: affluent 時(shí)間: 2025-3-28 10:39
Drugs Affecting Epigenetic Modifications of ABC Transporters for Drug Resistance,een found to extrude anticancer drugs from the inside of the cells to their outside for the protection of the cells from the drugs, resulting in the drug resistance. However, the mechanisms of how cancer cells acquire ABC transporter-mediated drug resistance have not yet been fully understood. There作者: Unsaturated-Fat 時(shí)間: 2025-3-28 14:38 作者: 口訣 時(shí)間: 2025-3-28 20:09
Role of Breast Cancer Resistance Protein (BCRP, ABCG2) in Cancer Outcomes and Drug Resistance, chemotherapeutics or to sensitize cancer cells that express BCRP to chemotherapy have not been fruitful. This review will examine the most current literature probing BCRP’s role in ADME of cancer therapeutic agents and drug resistance.作者: ingrate 時(shí)間: 2025-3-29 01:35 作者: 痛苦一生 時(shí)間: 2025-3-29 05:25 作者: 使迷醉 時(shí)間: 2025-3-29 10:28
978-3-319-37996-8Springer International Publishing Switzerland 2015作者: AXIOM 時(shí)間: 2025-3-29 13:02
Resistance to Targeted ABC Transporters in Cancer978-3-319-09801-2Series ISSN 2196-5501 Series E-ISSN 2196-551X 作者: 注意 時(shí)間: 2025-3-29 18:20 作者: dainty 時(shí)間: 2025-3-29 20:17
https://doi.org/10.1007/978-3-319-09801-2P-glycoprotein; anticancer drugs; multidrug resistance; nanotechnology; antibacterial drug resistance作者: BARB 時(shí)間: 2025-3-30 01:56
